Incredible news as we go further into the era of treatment. Alzheimer's Association is dedicated to finding the cause and the cure for Alzheimer's and all other dementia, while at the same time taking care of those living with the disease, their caregivers and their families. #endalz
Breaking News: The FDA has granted approval of Kisunla (donanemab) for the treatment of people living with early symptomatic Alzheimer’s disease. We celebrate Kisunla’s approval as more options mean greater opportunity for more time. This is the third approval of an Alzheimer’s treatment that changes the underlying course of the disease. bit.ly/3XIyyvf
The dedication and hard work of the Alzheimer's Association are truly commendable. We're inspired by the strides being taken towards finding the cause and cure for Alzheimer's. How can businesses further support your mission?